1.
Targeting the RAS pathway by mitogen-activated protein kinase inhibitors. Swiss Med Wkly [Internet]. 2015 Dec. 13 [cited 2025 Oct. 13];145(5152):w14207. Available from: https://www.smw.ch/index.php/smw/article/view/2128